Home › Encyclopedia › Taltirelin: Research Status and Trial Data
Research / Unapproved

Taltirelin: Research Status and Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC17H23N7O5
Molecular weight405.4 g/mol
Registered trials1
PubChem CID114750

Key Takeaways

  • Taltirelin has no FDA-approved label and is classified as an investigational research compound.
  • Its chemical identity is documented in public chemistry databases, including a PubChem entry (CID 114750).
  • Only one trial is registered for taltirelin in the available trial data.
  • That trial focused on an orally disintegrating tablet formulation for ataxia related to spinocerebellar degeneration.

What Taltirelin Is

Taltirelin is a synthetic compound with the molecular formula C17H23N7O5 and a molecular weight of about 405.4. It does not carry an FDA-approved label, so there is no established indication, mechanism statement, or brand name on file. Its structure and identity are catalogued under PubChem CID 114750, but this listing reflects chemistry data rather than clinical approval.

Trial Footprint

The available data shows one registered trial for taltirelin. That study evaluated a 5 mg orally disintegrating tablet formulation of taltirelin in people with ataxia caused by spinocerebellar degeneration. The trial is listed as completed. Beyond this single record, no additional trial activity is documented in the data reviewed.

FAQ

Is taltirelin FDA-approved?
No. Taltirelin does not have an FDA-approved label, and the available data does not list any approved indication or brand name. It is best described as an investigational research compound.
What is taltirelin used for in research?
The one registered trial in the available data studied an orally disintegrating tablet form of taltirelin in people with ataxia linked to spinocerebellar degeneration. This does not establish an approved or proven use for the compound generally.
How many clinical trials have studied taltirelin?
The data reviewed lists a single registered trial for taltirelin, which has been completed. This suggests a limited documented trial footprint compared to approved drugs.
What is the chemical structure of taltirelin?
Taltirelin has the molecular formula C17H23N7O5 and a molecular weight of approximately 405.4. Its structure and identifiers are catalogued in PubChem under CID 114750.
Are there known side effects of taltirelin?
No adverse event report data was available for taltirelin in the sources reviewed, so no side effect pattern can be summarized here. This absence reflects a gap in available reporting data, not confirmation of safety.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-04